A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors
Supportive Care in Cancer · 2024-06 · 32 (6)
DOI: 10.1007/s00520-024-08536-w ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 06.05.2024. Verfasst von Mei Ling Ng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Fatigue, Neoplasms, Rosmarinic Acid, Depsides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: The Malaysian Ministry of Agriculture, Malaysia.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- EMAN Research Ltd, Symonston, Australia.
- College of Health & Medicine, Australian National University, Canberra, Australia.
- Faculty of Pharmacy, SEGi University, Petaling Jaya, Malaysia.
- EMAN Biodiscoveries Sdn. Bhd, Sungai Petani, Malaysia.
- Department of Pharmacology, Faculty of Medicine, Quest International University, Ipoh, Malaysia.
Förderung
- The Malaysian Ministry of Agriculture, Malaysia
Zitieren
APA
Ng, M. L., Majid, A. M. S. A., Yee, S. M., Natesan, V., Basheer, M. K. A., Gnanasekaran, A., Al-Suede, F. S. R., Parish, C., Dalal, M., Ming, L. C., Nazari V, M., Khan, S. S., Stn Hameed Sultan, S. B., Babu, K. G., Majid, A. S. A., & Abdul Aziz, M. A. S. (2024). A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors. Supportive Care in Cancer, 32(6). https://doi.org/10.1007/s00520-024-08536-w
Vancouver
Ng ML, Majid AMSA, Yee SM, Natesan V, Basheer MKA, Gnanasekaran A, et al. A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors. Supportive Care in Cancer. 2024;32(6). doi:10.1007/s00520-024-08536-w
BibTeX
@article{Ng2024,
author = {Ng, Mei Ling and Majid, Amin Malik Shah Abdul and Yee, Siew Mei and Natesan, V and Basheer, Mohamed Khadeer Ahamed and Gnanasekaran, Ashok and Al-Suede, Fouad Saleih Resq and Parish, Christopher and Dalal, Meena and Ming, Long Chiau and Nazari V, Mansoureh and Khan, Shamsuddin Sultan and Stn Hameed Sultan, Siti Balkees and Babu, K Govind and Majid, Aman Shah Abdul and Abdul Aziz, Mohamed Amir Shah},
title = {A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors},
journal = {Supportive Care in Cancer},
year = {2024},
volume = {32},
number = {6},
doi = {10.1007/s00520-024-08536-w}
}
EUVIMED